Latest News Archives - Page 13 of 13

Complete or Culprit Lesion

I have a personal interest in this important trial as I was the Chief Investigator for this study in East Kent at the William Harvey Hospital in Ashford in my role as lead for cardiovascular research in East Kent.

Complete Revascularization with Multivessel PCI for Myocardial Infarction

October 10, 2019; N Engl J Med 2019; 381:1411-1421; DOI: 10.1056/NEJMoa1907775

Among patients with heart attacks due to a blocked artery (culprit lesion) and bystander disease in other coronary arteries this trial demonstrated that complete revascularization (stent insertion) was superior to culprit-lesion-only stenting.

Patients with all lesions (the segments which are narrowed) treated benefitted from a reduction of cardiovascular death or myocardial infarction. I consider it therefore to be best practice that all patients with bystander lesions get those stented during same hospitalisation or shortly after discharge.

click her for the article: https://www.nejm.org/doi/full/10.1056/NEJMoa1907775

17 November 2019/by Dr Konrad Grosser

Gout medication improves heart attack outcomes

A new New England Journal of Medicine publication suggests that an old gout medication may significantly help patients after an acute heart attack.

I found this study particularly interesting . It provides valuable information for patients. The medication appears to improve outcomes after having had a heart attack. It is a simple and safe drug usually used for gout.

click here for more information

https://www.nejm.org/doi/full/10.1056/NEJMoa1912388?query=featured_home

17 November 2019/by Dr Konrad Grosser

Should You Stop The Stomach Tablet Your Cardiologist Prescribed?

As you may have read in recent high profile publications there may be a link between taking proton pump inhibitor drugs (PPIs) and dementia as well as other side effects such as osteoporosis, amongst others.

European Society of Cardiology 2018 Update

I have just returned from the European Society of Cardiology meeting 2018 in Munich Germany and found it very useful. There are some very interesting studies and findings, which I hope to share with you in the next few months.